CFG
89
-4
CMS
57
-3
DD
60
-3
C
81
-3
AN
58
-2
BWA
53
-3
BRK.B
33
-3
CNP
52
2
COST
50
2
A
60
-2
BXP
46
-4
DE
58
-4
CPB
25
-2
AAPL
45
-3
BEN
57
11
ADSK
59
-3
APH
64
-3
CF
53
2
AEP
64
2
AFL
48
-4
CFG
89
-4
CMS
57
-3
DD
60
-3
C
81
-3
AN
58
-2
BWA
53
-3
BRK.B
33
-3
CNP
52
2
COST
50
2
A
60
-2
BXP
46
-4
DE
58
-4
CPB
25
-2
AAPL
45
-3
BEN
57
11
ADSK
59
-3
APH
64
-3
CF
53
2
AEP
64
2
AFL
48
-4
Financhill
Back

Strategy Vs. Kymera Therapeutics Industry Stock Comparison

Sell
48

MSTR
Strategy

Last Price:
$395.00
Seasonality Move:
8.05%
Buy
70

KYMR
Kymera Therapeutics

Last Price:
$43.57
Seasonality Move:
5.78%
Sell
48
Strategy (MSTR) is a Sell

Is Strategy a Buy, Sell or Hold?

  • The current Strategy [MSTR] share price is $403.99. The Score for MSTR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • MSTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $44.79. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MSTR Stock Price Chart

What is Strategy's stock price today?

  • The Strategy share price today is $403.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSTR is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $44.79
    The current trend is moderately bearish and KYMR is experiencing slight buying pressure.

MSTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.46 Buy
Relative Strength Index (14 RSI): 57.81 Buy
Chaikin Money Flow: -4950535 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.92 Buy
Relative Strength Index (14 RSI): 58.43 Buy
Chaikin Money Flow: 47554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MSTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 389.98 Buy
20-day SMA: 382.97 Buy
50-day SMA: 385.64 Buy
200-day SMA: 318.63 Buy
8-day EMA: 391.09 Buy
20-day EMA: 385.49 Buy
50-day EMA: 374.38 Buy
200-day EMA: 311.73 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.11 Sell
20-day SMA: 46.32 Sell
50-day SMA: 38 Buy
200-day SMA: 39.54 Buy
8-day EMA: 44.94 Sell
20-day EMA: 44.02 Buy
50-day EMA: 39.8 Buy
200-day EMA: 37.62 Buy

Strategy Earnings Growth & MSTR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, a decrease this year of $13.19 per share, and an increase next year of $16.05 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.17 per share, a decrease this year of $0.67 per share, and a decrease next year of $0.49 per share.

Strategy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):